v3.2.0.727
Condensed Consolidated Statements of Cash Flows (Unaudited) Statement - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Interest Paid $ 2,875 $ 2,875
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 60,287 75,557
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 23,423 18,372
Amortization of deferred financing fees and accretion of debt discount 9,300 5,085
Deferred revenue recognized (86,022) (74,336)
Increase (Decrease) in deferred revenue 90,776 256,859
Deferred income taxes (14,547) (14,899)
Share-based Compensation 6,299 9,721
Other 631 288
Decrease (increase) in assets:    
Receivables (57,015) (268,505)
Other current assets (458) (3,191)
Increase (decrease) in liabilities:    
Accounts payable (1,453) (12,443)
Other accrued expenses (18,582) 283
Accrued taxes payable 14,427 37,490
Net cash provided by operating activities 27,066 30,281
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of short-term investments (259,468) (263,395)
Sales of short-term investments 134,286 174,742
Purchases of property and equipment (1,329) (1,466)
Capitalized patent costs (16,191) (17,112)
Acquisition of patents (20,000) (25,275)
Net cash used in investing activities (162,702) (132,506)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Noncontrolling Interest, Increase from Business Combination 2,551 2,550
Proceeds from (Payments for) Other Financing Activities 4,500 0
Net proceeds from exercise of stock options 26 353
Proceeds from issuance of convertible senior notes 316,000 0
Payments for Hedge, Financing Activities (59,376) 0
Proceeds from Issuance of Warrants 42,881 0
Payments of Debt Issuance Costs (9,403) 0
Dividends paid (14,665) (8,088)
Excess Tax Benefit (Tax Deficiency) from Share-based Compensation, Financing Activities 2,163 1,196
Repurchase of common stock (70,572) (8,454)
Net cash provided (used) by financing activities 214,105 (12,443)
NET INCREASE IN CASH AND CASH EQUIVALENTS 78,469 (114,668)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 428,567 497,714
CASH AND CASH EQUIVALENTS, END OF PERIOD 507,036 383,046
Income Taxes Paid 36,764 22,823
Dividend payable 7,243  
Accrued capitalized patent costs and acquisition of patents 421 21,034
Payments for Purchase of Other Assets $ 0 $ 19,250